Zoltan Szallasi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Radical Prostatectomy

Dna Damage Response

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Miklos Diossy, Viktoria Tisza, Hua Li, Pranshu Sahgal, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nousome, Claire Kuo, Jiji Jiang, Yongmei Chen, Reinhard Ebner, Isabell A Sesterhenn, Joel T Moncur, Gregory T Chesnut, Gyorgy Petrovics, Gregory T Klus, Gabor Valcz, Pier Vitale Nuzzo, Dezso Ribli, Judit Börcsök, Aurel Prosz, Marcin Krzystanek, Thomas Ried, Dávid Szüts, Kinza Rizwan, Salma Kaochar, Shailja Pathania, Alan D' Andrea, Istvan Csabai, Shiv Srivastava, Matthew L Freedman, Albert Dobi, Sandor Spisak, Zoltan Szallasi
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression. NPJ precision oncology 8 (1) (2024)
Zoltan Szallasi, Aurel Prosz, Zsofia Sztupinszki, Judit Moldvay
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer? Oncoimmunology 13 (1) (2024)
Zoltan Szallasi, Aurel Prosz, Zsofia Sztupinszki, Judit Moldvay
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer? Oncoimmunology 13 (1) (2024)
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Sándor Spisák, Viktoria Tisza, Pier Vitale Nuzzo, Ji-Heui Seo, Balint Pataki, Dezső Ribli, Zsofia Sztupinszki, Connor Bell, Mersedeh Rohanizadegan, David R Stillman, Sarah Abou Alaiwi, Alan H Bartels, Marton Papp, Anamay Shetty, Forough Abbasi, Xianzhi Lin, Kate Lawrenson, Simon A Gayther, Mark Pomerantz, Sylvan Baca, Norbert Solymosi, Istvan Csabai, Zoltan Szallasi, Alexander Gusev, Matthew L Freedman
Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. Nature communications 14 (1) (2023)
Aurel Prosz, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T Klus, Judit Börcsök, Zsofia Sztupinszki, Timothy Hanlon, Miklos Diossy, Laura Vizkeleti, Dag Rune Stormoen, Istvan Csabai, Helle Pappot, Joseph Vijai, Kenneth Offit, Thomas Ried, Nilay Sethi, Kent W Mouw, Sandor Spisak, Shailja Pathania, Zoltan Szallasi
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. bioRxiv : the preprint server for biology (2023)
Sándor Spisák, Viktoria Tisza, Pier Vitale Nuzzo, Ji-Heui Seo, Balint Pataki, Dezső Ribli, Zsofia Sztupinszki, Connor Bell, Mersedeh Rohanizadegan, David R Stillman, Sarah Abou Alaiwi, Alan B Bartels, Marton Papp, Anamay Shetty, Forough Abbasi, Xianzhi Lin, Kate Lawrenson, Simon A Gayther, Mark Pomerantz, Sylvan Baca, Norbert Solymosi, Istvan Csabai, Zoltan Szallasi, Alexander Gusev, Matthew L Freedman
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Yuzhen Zhou, Judit Börcsök, Elio Adib, Sophia C Kamran, Alexander J Neil, Konrad Stawiski, Dory Freeman, Dag Rune Stormoen, Zsófia M Sztupinszki, Amruta Samant, Amin H Nassar, Raie T Bekele, Timothy Hanlon, Henkel Valentine, Ilana Epstein, Bijaya Sharma, Kristen Felt, Philip Abbosh, Chin-Lee Wu, Jason Alexander Efstathiou, David T Miyamoto, William Anderson, Zoltan Szallasi, Kent W Mouw
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer. Science advances 9 (47) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Aurel Prosz, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T Klus, Judit Börcsök, Zsofia Sztupinszki, Timothy Hanlon, Miklos Diossy, Laura Vizkeleti, Dag Rune Stormoen, Istvan Csabai, Helle Pappot, Joseph Vijai, Kenneth Offit, Thomas Ried, Nilay Sethi, Kent W Mouw, Sandor Spisak, Shailja Pathania, Zoltan Szallasi
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. bioRxiv : the preprint server for biology (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Ines Mota, Enrico Patrucco, Cristina Mastini, Navin R Mahadevan, Tran C Thai, Elisa Bergaggio, Taek-Chin Cheong, Giulia Leonardi, Elif Karaca-Atabay, Marco Campisi, Teresa Poggio, Matteo Menotti, Chiara Ambrogio, Dario Livio Longo, Susan Klaeger, Hasmik Keshishian, Zsófia M Sztupinszki, Zoltan Szallasi, Derin B Keskin, Jonathan S Duke-Cohan, Bruce Reinhold, Steven A Carr, Catherine J Wu, Kelly D Moynihan, Darrell J Irvine, David A Barbie, Ellis L Reinherz, Claudia Voena, Mark M Awad, Rafael B Blasco, Roberto Chiarle
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer. Nature cancer (2023)
Aurel Prosz, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T Klus, Judit Börcsök, Zsofia Sztupinszki, Timothy Hanlon, Miklos Diossy, Laura Vizkeleti, Dag Rune Stormoen, Istvan Csabai, Helle Pappot, Joseph Vijai, Kenneth Offit, Thomas Ried, Nilay Sethi, Kent W Mouw, Sandor Spisak, Shailja Pathania, Zoltan Szallasi
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. bioRxiv : the preprint server for biology (2023)
Dan Chen, Judit Z Gervai, Ádám Póti, Eszter Németh, Zoltán Szeltner, Bernadett Szikriszt, Zsolt Gyüre, Judit Zámborszky, Marta Ceccon, Fabrizio d'Adda di Fagagna, Zoltan Szallasi, Andrea L Richardson, Dávid Szüts
BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1. Nature communications 13 (1) (2022)
Morten Nielsen, Mario Presti, Zsófia M Sztupinszki, Agnete Witness Præst Jensen, Arianna Draghi, Christopher Aled Chamberlain, Aimilia Schina, Christina Westmose Yde, John B Wojcik, Zoltan Szallasi, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy. Cancer immunology research 10 (10) (2022)
Chenkui Miao, Takuya Tsujino, Tomoaki Takai, Fu Gui, Takeshi Tsutsumi, Zsófia M Sztupinszki, Zengjun Wang, Haruhito Azuma, Zoltan Szallasi, Kent W Mouw, Lee Zou, Adam S Kibel, Li Jia
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science advances 8 (7) (2022)
Jintao Guo, Ying Zhou, Chaoqun Xu, Qinwei Chen, Zsófia M Sztupinszki, Judit Börcsök, Canqiang Xu, Feng Ye, Weiwei Tang, Jiapeng Kang, Lu Yang, Jiaxin Zhong, Taoling Zhong, Tianhui Hu, Rongshan Yu, Zoltan Szallasi, Xianming Deng, Qiyuan Li
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers. Cancer research 81 (16) (2021)
Judit Börcsök, Miklos Diossy, Zsófia M Sztupinszki, Aurel Prosz, Viktoria Tisza, Sándor Spisák, Orsolya Rusz, Dag Rune Stormoen, Helle Pappot, Istvan Csabai, Søren Brunak, Kent W Mouw, Zoltan Szallasi
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Sidsel C Lindgaard, Zsófia M Sztupinszki, Emil Maag, Inna Markovna Chen, Julia Sidenius Johansen, Benny Vittrup Jensen, Stig E Bojesen, Dorte L Nielsen, Carsten Palnaes Hansen, Jane P Hasselby, Kaspar R Nielsen, Zoltan Szallasi
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Miklos Diossy, Zsofia Sztupinszki, Judit Börcsök, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, Dávid Szüts, Zoltan Szallasi
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures. NPJ precision oncology 5 (1) (2021)
Zsófia M Sztupinszki, Miklos Diossy, Judit Börcsök, Aurel Prosz, Nanna Cornelius, Maj K Kjeldsen, Mansoor R Mirza, Zoltan Szallasi
Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Sunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Staffan Holmberg-Thyden, Annie Borch, Kathrine Valentini Jensen, Govardhan Anande, Amalie Kai Bentzen, Andrea Marion Marquard, Tripti Tamhane, Marianne Bach Treppendahl, Anne Ortved Gang, Inge Høgh Dufva, Zoltan Szallasi, Nicola Ternette, Anders Gorm Pedersen, Aron Charles Eklund, John E Pimanda, Kirsten Grønbæk, Sine Reker Hadrup
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers. Nature communications 11 (1) (2020)
Aurélie Fluckiger, Romain Daillère, Mohamed Sassi, Barbara Susanne Sixt, Peng Liu, Friedemann Loos, Corentin Richard, Catherine Rabu, Maryam Tidjani Alou, Anne-Gaëlle Goubet, Fabien Lemaitre, Gladys Ferrere, Lisa Derosa, Connie P M Duong, Meriem Messaoudene, Andréanne Gagné, Philippe Joubert, Luisa De Sordi, Laurent Debarbieux, Sylvain Simon, Clara-Maria Scarlata, Maha Ayyoub, Belinda Palermo, Francesco Facciolo, Romain Boidot, Richard Wheeler, Ivo Gomperts Boneca, Zsófia M Sztupinszki, Krisztian Papp, Istvan Csabai, Edoardo Pasolli, Nicola Segata, Carlos López-Otín, Zoltan Szallasi, Fabrice Andre, Valerio Iebba, Valentin Quiniou, David Klatzmann, Jacques Boukhalil, Saber Khelaifia, Didier Raoult, Laurence Albiges, Bernard Escudier, Alexander Eggermont, Fathia Mami-Chouaib, Paola Nistico, François Ghiringhelli, Bertrand Routy, Nathalie Labarrière, Vincent Cattoir, Guido Kroemer, Laurence Zitvogel
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science (New York, N.Y.) 369 (6506) (2020)
Judit Börcsök, Zsófia M Sztupinszki, Raie Bekele, Sizhi P Gao, Miklos Diossy, Amruta S Samant, Kasia M Dillon, Viktoria Tisza, Sándor Spisák, Orsolya Rusz, Istvan Csabai, Helle Pappot, Zoë J Frazier, David J Konieczkowski, David R Liu, Naresh Vasani, James A Rodrigues, David B Solit, Jean H Hoffman-Censits, Elizabeth R Plimack, Jonathan E Rosenberg, Jean-Bernard Lazaro, Mary-Ellen Taplin, Gopa Iyer, Søren Brunak, Rita Lozsa, Eliezer M Van Allen, Dávid Szüts, Kent W Mouw, Zoltan Szallasi
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2020)
Julie Le Naour, Peng Liu, Liwei Zhao, Sandy Adjemian, Zsofia Sztupinszki, Julien Taieb, Claire Mulot, Aymeric Silvin, Charles-Antoine Dutertre, Florent Ginhoux, Allan Sauvat, Giulia Cerrato, Francesca Castoldi, Isabelle Martins, Gautier Stoll, Juliette Paillet, Khady Mangane, Cornelia Richter, Oliver Kepp, Maria Chiara Maiuri, Federico Pietrocola, Peter Vandenabeele, Fabrice Andre, Suzette Delaloge, Zoltan Szallasi, Pierre Laurent-Puig, Jessica Zucman-Rossi, Laurence Zitvogel, Jonathan G Pol, Erika Vacchelli, Guido Kroemer
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer discovery 11 (2) (2020)